Kaneko Shohei, Ookawara Susumu, Morishita Yoshiyuki
Department of Nephrology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Int J Nephrol Renovasc Dis. 2022 May 24;15:185-195. doi: 10.2147/IJNRD.S357130. eCollection 2022.
Magnesium (Mg) is an essential element that is associated with various physiological functions, such as maintenance of blood pressure, muscle contraction, and nerve function. In patients undergoing hemodialysis, hypomagnesemia is associated with cardiovascular and all-cause mortality. However, in patients undergoing peritoneal dialysis (PD), clinical factors associated with Mg have not been fully investigated.
Clinical factors including anthropometric data, comorbidities, laboratory data, medications, and dialysis methods were collected from the medical records of patients undergoing PD. The associations of these factors with the serum Mg concentration were investigated by univariate and multivariate analyses.
Sixty patients undergoing PD were investigated. The univariate analysis showed that the serum Mg concentration was significantly associated with treatment by hybrid PD (daily PD + once-weekly hemodialysis) (β = 0.264, P = 0.04), administration of phosphate binders (β = 0.294, P = 0.02), the serum C-reactive protein concentration (β = -0.318, P = 0.01), the serum potassium (K) concentration (β = 0.451, P < 0.01), and the serum intact parathormone concentration (β = -0.333, P = 0.01). The multivariate analysis using these factors showed an independent association between the serum Mg and K concentrations (β = 0.333, P = 0.01).
The serum Mg concentration was independently associated with the serum K concentration in patients undergoing PD.
镁(Mg)是一种必需元素,与多种生理功能相关,如维持血压、肌肉收缩和神经功能。在接受血液透析的患者中,低镁血症与心血管疾病及全因死亡率相关。然而,在接受腹膜透析(PD)的患者中,与镁相关的临床因素尚未得到充分研究。
从接受PD治疗的患者病历中收集包括人体测量数据、合并症、实验室数据、用药情况和透析方法等临床因素。通过单因素和多因素分析研究这些因素与血清镁浓度的关联。
对60例接受PD治疗的患者进行了研究。单因素分析显示,血清镁浓度与混合性腹膜透析(每日腹膜透析 + 每周一次血液透析)治疗显著相关(β = 0.264,P = 0.04)、与使用磷结合剂相关(β = 0.294,P = 0.02)、与血清C反应蛋白浓度相关(β = -0.318,P = 0.01)、与血清钾(K)浓度相关(β = 0.451,P < 0.01)以及与血清全段甲状旁腺激素浓度相关(β = -0.333,P = 0.01)。使用这些因素进行的多因素分析显示血清镁浓度与钾浓度之间存在独立关联(β = 0.333,P = 0.01)。
在接受PD治疗的患者中,血清镁浓度与血清钾浓度独立相关。